Lupin surges on securing USFDA approval for Dapagliflozin tablets
Mumbai, April 8 (Udaipur Kiran): Lupin is currently trading at Rs. 2334.95, up by 38.35 points or 1.67% from its previous closing of Rs. 2296.60 on the BSE. The scrip opened at Rs. 2334.95 and has touched a high and low of Rs. 2334.95 and Rs. 2313.70 respectively. So far 150 shares were traded on … Read more



